Poor performance status is associated with increased mortality in patients with cirrhosis

ES Orman, M Ghabril, N Chalasani - Clinical Gastroenterology and …, 2016 - Elsevier
… We sought to examine the association between KPS and mortality in waitlisted patients
with cirrhosis. Our hypothesis was that patients with worse performance status would have …

[HTML][HTML] Prevalence of poor performance status in lung cancer patients: implications for research

RC Lilenbaum, J Cashy, TA Hensing, S Young… - Journal of Thoracic …, 2008 - Elsevier
patients in oncology practice presents with a poor PS. The risk of poor PS is greatest for lung
cancer patients, … Determining PS is subjective and varies between the patient and provider. …

Management of patients with lung cancer and poor performance status

A Gajra, AS Marr, AK Ganti - Journal of the National Comprehensive …, 2014 - jnccn.org
Patients who are able to care for themselves but are unable to perform … poor performance
status (PS). Individuals who fulfill these criteria constitute a significant proportion of all patients

Outcome of treatment in patients with small cell lung cancer in poor performance status

R Bahij, SS Jeppesen, KE Olsen, U Halekoh… - Acta …, 2019 - Taylor & Francis
patients aged 80–84 years receive no CT [Citation17]. Oncologists often use performance
status to decide whether a patient … CT on elderly patients with poor PS as in the current study. …

Treatment of patients with metastatic colorectal cancer and poor performance status: current evidence and challenges

LSS Rocha, RP Riechelmann - Clinics, 2018 - SciELO Brasil
… Cooperative Oncology Group performance status ≥2. … and one was an individual patient
meta-analysis. Although some … colorectal cancer patients with poor performance status is scarce…

The “Lazarus Response” in treatment-naïve, poor performance status patients with non–small-cell lung cancer and epidermal growth factor receptor mutation

CJ Langer - Journal of Clinical Oncology, 2009 - ascopubs.org
patients was 34% when estimated by providers and 48% when determined by patients
standard therapy in advanced NSCLC patients with very poor performance status (PS 3 to 4)…

Ongoing challenges of using immunotherapy in special populations: Poor performance status patients, elderly patients, and people living with HIV

V Gounant, A Lavolé, E Quoix - Lung Cancer, 2020 - Elsevier
patients. However, most clinical trials on ICIs conducted so far have either excluded patients
with poor performance status (PS… a minor proportion of elderly patients despite the lack of an …

Poor-performance status assessment of patients with non-small cell lung cancer remains vague and blurred in the immunotherapy era

A Friedlaender, GL Banna, L Buffoni, A Addeo - Current oncology reports, 2019 - Springer
performance status (PS)0-1 patients. ICI studies have for the vast majority excluded patients
with poor performance statuspoor response to treatments. Data on the activity of ICIs in PS2 …

Poor performance status is associated with early death in patients with pulmonary tuberculosis

S De Vallière, RD Barker - Transactions of the Royal Society of …, 2006 - academic.oup.com
poor performance status showed a strong association with early death among adult patients
… We think that the recording of performance status could be a useful clinical, epidemiological …

Performance status and cytoreductive nephrectomy: redefining management in patients with poor performance

B Shuch, JC La Rochelle, J Wu, T Klatte… - … Journal of the …, 2008 - Wiley Online Library
… numbers of patients.10, … patients with a poor performance status who underwent CN and
investigated whether surgery prolonged survival.7, 9 Patients with a worse performance status